Cargando…
Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study
Background: A recent randomized controlled study showed that 66.7% (66/99) and 37.4% (37/99) of people undergoing remote electrical neuromodulation (REN), a novel non-pharmacological migraine treatment, achieve pain relief and pain freedom, respectively, at 2 h post-treatment. The participants who c...
Autores principales: | Marmura, Michael J., Lin, Tamar, Harris, Dagan, Ironi, Alon, Rosen, Noah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154105/ https://www.ncbi.nlm.nih.gov/pubmed/32318014 http://dx.doi.org/10.3389/fneur.2020.00226 |
Ejemplares similares
-
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications
por: Rapoport, Alan M., et al.
Publicado: (2019) -
Remote Electrical Neuromodulation (REN) for the Acute Treatment of Menstrual Migraine: a Retrospective Survey Study of Effectiveness and Tolerability
por: Nierenburg, Hida, et al.
Publicado: (2021) -
Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
por: Ailani, Jessica, et al.
Publicado: (2022) -
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
por: Yarnitsky, David, et al.
Publicado: (2019) -
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
por: Nierenburg, Hida, et al.
Publicado: (2020)